Alnylam Pharmaceuticals, Inc. (ALNY)

303.00 +1.89 (+0.63%) USD  |  NASDAQ  |  May 06, 16:00
303.00 0.00 (0.00%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Glaukos Corp. Upgrade